Novavax is undervalued, presenting an attractive risk-reward profile for long-term investors. Click here to find out why NVAX ...

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

VGXI, Inc., a leading contract development and manufacturing organization (CDMO) specializing in plasmid DNA biopharmaceuticals, including for use in gene therapies, DNA vaccines, and RNA medicines, ...

On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...

The FDA and NIH announced a joint nutrition research venture to better understand the causes of diet-related chronic disease, ...

President Trump confirmed late yesterday that he would revive a “most-favored nation” drug pricing policy, aiming to tie U.S.

Meanwhile, Axios reports the FDA is making plans to use AI in its decision-making. Also: President Donald Trump is set to sign an executive order to bring down the cost of meds.

The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

May, 12 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers ...